Reuters 20 January 2021
![MOSCOW, RUSSIA JANUARY 20, 2021: A mobile vaccination team member shows a vial of component 1 of the Gam-COVID-Vac vaccine (under the brand name of Sputnik V) at a temporary COVID-19 vaccination site at the Helikon Opera Theatre. Since the start of the pandemic, Moscow has confirmed more than 898,400 cases of COVID-19. Since the beginning of the year 2021, the number of new confirmed cases has been increasing in Moscow by more than 3,000 daily. Artyom Geodakyan/TASS (Photo by Artyom Geodakyan\TASS via Getty Images)]({"default":{"load":"default","w":"80","h":"53","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1cV6f4.img?h=532&w=799&m=6&q=60&o=f&l=f&x=2973&y=989"},"size3column":{"load":"default","w":"62","h":"42","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1cV6f4.img?h=416&w=624&m=6&q=60&o=f&l=f&x=2973&y=989"},"size2column":{"load":"default","w":"62","h":"42","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/BB1cV6f4.img?h=416&w=624&m=6&q=60&o=f&l=f&x=2973&y=989"}})
© Artyom Geodakyan\TASS via Getty Images MOSCOW, RUSSIA JANUARY 20, 2021: A mobile vaccination team member shows a vial of component 1 of the Gam-COVID-Vac vaccine (under the brand name of Sputnik V) at a temporary COVID-19 vaccination site at the Helikon Opera Theatre. Since the start of the pandemic, Moscow has confirmed more than 898,400 cases of COVID-19. Since the beginning of the year 2021, the number of new confirmed cases has been increasing in Moscow by more than 3,000 daily. Artyom Geodakyan/TASS (Photo by Artyom Geodakyan\TASS via Getty Images)
Jan 20 (Reuters) - Russia's sovereign wealth fund RDIF has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday, moving it closer to wider adoption across the globe.
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The country would submit a formal application to the European Union in February for approval of its Sputnik V coronavirus vaccine, RDIF chief Kirill Dmitriev had said in an interview at the Reuters Next conference last week.
(Reporting by Amruta Khandekar; Editing by Shinjini Ganguli, Bernard Orr)
